+++ Jetzt mit Kryptowährungen handeln und mehr über Bitcoin erfahren!** +++-w-
08.07.2019 17:08:00

Why Geron Corporation Stock Bolted Higher in the First Half of 2019

Shares of the prerevenue biotech Geron Corporation (NASDAQ: GERN) gained an astounding 41% during the first six months of 2019, according to data from S&P Global Market Intelligence. What caused investors to pile into this clinical-stage biotech stock in the first half of the year?Geron's stock has been marching higher in response to the news that its telomerase inhibitor, imetelstat, will enter a pivotal-stage trial for the rare blood disorder known as lower-risk myelodysplastic syndromes (MDS) this summer.Image Source: Getty Images.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"